Paper · 40071471

Genomic and transcriptomic sequencing in prostate cancer.

Rifai S and 7 others. Curr Opin Oncol, 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Genomic and transcriptomic sequencing in prostate cancer. Papers, record 40071471. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40071471

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Genomic and transcriptomic sequencing in prostate cancer.; PubMed
Journal: Curr Opin Oncol; PubMed
Year: 2025; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/40071471/; PubMed
DOI: https://doi.org/10.1097/cco.0000000000001136; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13034484/; PubMed
The journal: https://conductscience.org/library/journal-index/9007265; PubMed
Citations, by iCite: 1; iCite
Revised in PubMed: 2026-08-13; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Rifai S	Safiullah
2	Rifai A	Azimullah
3	Shi X	Xiaolei
4	Khan MA	Mohammad Afnan
5	Guang W	Wei
6	Wang L	Linbo
7	Tallon L	Luke
8	Hussain A	Arif

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Prostatic Neoplasms	Major topic
Genomics	Major topic
Transcriptome	Major topic
Humans
Male
High-Throughput Nucleotide Sequencing
Gene Expression Profiling

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
P30 CA134274	NCI NIH HHS	United States	P30CA134274	PubMed	NIH RePORTER
T32 CA154274	NCI NIH HHS	United States	T32CA154274	PubMed	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	35,294,956	Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors.	PLoS One	2022	https://conductscience.org/library/papers/35294956	PubMed
2	37,686,024	Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation.	Int J Mol Sci	2023	https://conductscience.org/library/papers/37686024	PubMed
3	25,667,284	Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.	J Clin Oncol	2015	https://conductscience.org/library/papers/25667284	PubMed
4	26,334,920	Mapping RNA-seq Reads with STAR.	Curr Protoc Bioinformatics	2015	https://conductscience.org/library/papers/26334920	PubMed
5	20,121,268	An integrated system for DNA sequencing by synthesis using novel nucleotide analogues.	Acc Chem Res	2010	https://conductscience.org/library/papers/20121268	PubMed
6	24,075,185	Reliable identification of genomic variants from RNA-seq data.	Am J Hum Genet	2013	https://conductscience.org/library/papers/24075185	PubMed
7	30,918,253	Diagnosis of fusion genes using targeted RNA sequencing.	Nat Commun	2019	https://conductscience.org/library/papers/30918253	PubMed
8	26,996,076	Translating RNA sequencing into clinical diagnostics: opportunities and challenges.	Nat Rev Genet	2016	https://conductscience.org/library/papers/26996076	PubMed
9	30,589,920	Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.	JAMA Oncol	2019	https://conductscience.org/library/papers/30589920	PubMed
10	30,339,520	Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.	J Clin Oncol	2018	https://conductscience.org/library/papers/30339520	PubMed

1 to 10 of 77

See all 77 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40071471

GET https://conductscience.org/api/papers/v1/40071471/references?page=2

API reference For AI assistants